Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
MRNA
REGN
Add up to 3 more stocks
MRNA
Moderna, Inc.
+176.97%
$174.38+111.42At close: Aug 19, 2026, 4:00 PM ET
Market Cap
$69.19B
52W Range
$22.28 - $176.66
REGN
Regeneron Pharmaceuticals, Inc.
+3.78%
$840.84+30.60At close: Aug 19, 2026, 4:00 PM ET
Market Cap
$86.63B
52W Range
$541.00 - $844.90
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 20.80 |
| Forward P/E | N/A | 15.97 |
| P/B Ratio | 10.21 | 2.83 |
| P/S Ratio | 30.99 | 5.78 |
| P/FCF Ratio | N/A | 25.50 |
| EV/EBITDA | N/A | 19.86 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 55.4% | 84.9% |
| Operating Margin | -158.1% | 25.6% |
| Net Margin | -141.4% | 27.9% |
| ROE | -46.6% | 13.7% |
| ROA | -28.8% | 10.4% |
| ROIC | -39.2% | 9.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.29 | 3.34 |
| Quick Ratio | 2.18 | 2.78 |
| Debt/Equity | 0.19 | 0.06 |
| Interest Coverage | -307.40 | 81.69 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 0.4% |
| Payout Ratio | N/A | 8.4% |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.